PROM1 and Stroke: Furthermore, this study demonstrated that CD133+Exo treatment decreases oxidative stress, cardiomyocyte hypertrophy, and interstitial fibrosis and increases myocardial capillary density in the heart of T2DM-stroke mice [131].